Evidence map›Paper›PMID 25086038›Full record

ArticleThe Journal of biological chemistry2014

Multiple propofol-binding sites in a γ-aminobutyric acid type A receptor (GABAAR) identified using a photoreactive propofol analog.

Selwyn S Jayakar, Xiaojuan Zhou, David C Chiara, Zuzana Dostalova, Pavel Y Savechenkov, Karol S Bruzik, William P Dailey, Keith W Miller, Roderic G Eckenhoff, Jonathan B Cohen

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 115 citations in OpenAlex.

  1. Article
  2. GABADrug design, development and therapy · 2026
    Review
  3. Article
  4. Propofol reduces human TRPA1 activity in a warm environment.Biochemistry and biophysics reports · 2025
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Phenols and GABAFrontiers in pharmacology · 2024
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Modulation of the mammalian GABABritish journal of pharmacology · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Modulation of α1β3γ2 GABAProceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  19. Mechanistic basis of propofol-induced disruption of kinesin processivity.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  20. Review

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Selwyn S JayakarFrom the Departments of Neurobiology and.
Xiaojuan Zhouthe Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114.
David C ChiaraFrom the Departments of Neurobiology and.
Zuzana Dostalovathe Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114.
Pavel Y Savechenkovthe Department of Medicinal Chemistry and Pharmacognosy, University of Illinois at Chicago, Chicago, Illinois 60612, and.
Karol S Bruzikthe Department of Medicinal Chemistry and Pharmacognosy, University of Illinois at Chicago, Chicago, Illinois 60612, and.
William P Daileythe Department of Chemistry, University of Pennsylvania and.
Keith W Millerthe Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115.
Roderic G EckenhoffDepartment of Anesthesiology and Critical Care, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania 19104.
Jonathan B CohenFrom the Departments of Neurobiology and jonathan_cohen@hms.harvard.edu.
Massachusetts General Hospital · USHarvard University · USUniversity of Illinois Chicago · USUniversity of Pennsylvania · USInstitute of Neurobiology · BG

Funding

Synthetic Chemistry CoreP01GM058448 · NIGMS · MASSACHUSETTS GENERAL HOSPITAL · PI MILLER, KEITH W · 1999 to 2018
$33.6M
X-ray and Neutron Interferometry Studies of Anesthetic Interactions with VoltageP01GM055876 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI LOLL, PATRICK J · 1997 to 2017
$22.4M
NIGMS NIH HHS GM-55876NIGMS NIH HHS GM-58448NIGMS NIH HHS P01 GM055876NIGMS NIH HHS P01 GM058448
6 · The paper itself

Abstract

Propofol acts as a positive allosteric modulator of γ-aminobutyric acid type A receptors (GABAARs), an interaction necessary for its anesthetic potency in vivo as a general anesthetic. Identifying the location of propofol-binding sites is necessary to understand its mechanism of GABAAR modulation. [(3)H]2-(3-Methyl-3H-diaziren-3-yl)ethyl 1-(phenylethyl)-1H-imidazole-5-carboxylate (azietomidate) and R-[(3)H]5-allyl-1-methyl-5-(m-trifluoromethyl-diazirynylphenyl)barbituric acid (mTFD-MPAB), photoreactive analogs of 2-ethyl 1-(phenylethyl)-1H-imidazole-5-carboxylate (etomidate) and mephobarbital, respectively, have identified two homologous but pharmacologically distinct classes of intersubunit-binding sites for general anesthetics in the GABAAR transmembrane domain. Here, we use a photoreactive analog of propofol (2-isopropyl-5-[3-(trifluoromethyl)-3H-diazirin-3-yl]phenol ([(3)H]AziPm)) to identify propofol-binding sites in heterologously expressed human α1β3 GABAARs. Propofol, AziPm, etomidate, and R-mTFD-MPAB each inhibited [(3)H]AziPm photoincorporation into GABAAR subunits maximally by ∼ 50%. When the amino acids photolabeled by [(3)H]AziPm were identified by protein microsequencing, we found propofol-inhibitable photolabeling of amino acids in the β3-α1 subunit interface (β3Met-286 in β3M3 and α1Met-236 in α1M1), previously photolabeled by [(3)H]azietomidate, and α1Ile-239, located one helical turn below α1Met-236. There was also propofol-inhibitable [(3)H]AziPm photolabeling of β3Met-227 in βM1, the amino acid in the α1-β3 subunit interface photolabeled by R-[(3)H]mTFD-MPAB. The propofol-inhibitable [(3)H]AziPm photolabeling in the GABAAR β3 subunit in conjunction with the concentration dependence of inhibition of that photolabeling by etomidate or R-mTFD-MPAB also establish that each anesthetic binds to the homologous site at the β3-β3 subunit interface. These results establish that AziPm as well as propofol bind to the homologous intersubunit sites in the GABAAR transmembrane domain that binds etomidate or R-mTFD-MPAB with high affinity.

Indexed as

Binding SitesHumansKineticsPhotoaffinity LabelsPropofolReceptors, GABA-AGABRA1 protein, humanGABRB3 protein, humanPhotoaffinity LabelsPropofolReceptors, GABA-AAnesthesiaGABA ReceptorGeneral AnestheticsNicotinic Acetylcholine Receptors (nAChR)Photoaffinity LabelingPropofolProtein Drug Interaction

Identifiers

PMID25086038
PMCPMC4183786
OpenAlexW1972584910

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.